Evidence map›Paper›PMID 41230151›Full record

ArticleTranslational andrology and urology2025

Impact of preoperative SARS-CoV-2 infection on post-prostatectomy urinary continence and erectile function.

Weitao Zhong, Yilong Gao, Yanxiang Shao, Xiang Li

Abstract read
In one paragraph

Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Weitao Zhong *Department of Urology, West China Hospital, Sichuan University, Chengdu, China.
Yilong Gao *Department of Urology, West China Hospital, Sichuan University, Chengdu, China.
Yanxiang Shao *Department of Urology, West China Hospital, Sichuan University, Chengdu, China.
Xiang LiDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Urinary incontinence (UI) and erectile dysfunction (ED) are common sequelae after radical prostatectomy (RP), substantially affecting patients' quality of life. Since the coronavirus disease 2019 (COVID-19) pandemic, increasing attention has been given to the potential systemic effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), including endothelial dysfunction and hormonal alterations, which may influence functional recovery after surgery. This study aimed to investigate the impact of preoperative SARS-CoV-2 infection on postoperative urinary continence and erectile function in prostate cancer patients. Methods: A retrospective cohort of 298 patients undergoing RP was stratified into COVID-19 infected (n=166) and non-infected (n=132) groups based on preoperative reverse transcription polymerase chain reaction (RT-PCR) results. Functional outcomes were assessed using the International Index of Erectile Function-5 (IIEF-5) and Incontinence Quality of Life (I-QOL) scores at 6 months postoperatively. Results: At 6-month postoperative follow-up, the COVID-19 group had significantly lower IIEF-5 scores compared to controls in univariable analysis (median: 11 Conclusions: Preoperative COVID-19 infection was linked to reduced erectile function in univariable analysis but not after multivariable adjustment, and it had no significant effect on urinary continence. Sexual and urinary function were correlated in both groups, but this relationship was not modified by COVID-19 status.

Indexed as

coronavirus disease 2019 (COVID-19)erectile dysfunction (ED)Prostate cancerradical prostatectomy (RP)urinary incontinence (UI)

Identifiers

PMID41230151
PMCPMC12603816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.